BRPI0921303B8 - Agente redutor de rugas, composto, e, preparação externa para a pele. - Google Patents

Agente redutor de rugas, composto, e, preparação externa para a pele.

Info

Publication number
BRPI0921303B8
BRPI0921303B8 BRPI0921303A BRPI0921303A BRPI0921303B8 BR PI0921303 B8 BRPI0921303 B8 BR PI0921303B8 BR PI0921303 A BRPI0921303 A BR PI0921303A BR PI0921303 A BRPI0921303 A BR PI0921303A BR PI0921303 B8 BRPI0921303 B8 BR PI0921303B8
Authority
BR
Brazil
Prior art keywords
carbons
straight
branched alkyl
external skin
aromatic group
Prior art date
Application number
BRPI0921303A
Other languages
English (en)
Inventor
Chihiro Kondo
Noriko Suenobu
Takashi Yamasaki
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of BRPI0921303A2 publication Critical patent/BRPI0921303A2/pt
Publication of BRPI0921303B1 publication Critical patent/BRPI0921303B1/pt
Publication of BRPI0921303B8 publication Critical patent/BRPI0921303B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/17—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton
    • C07C309/18—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing carboxyl groups bound to the carbon skeleton containing amino groups bound to the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

agente redutor de rugas, composto, e, preparação externa para a pele. são fornecidos agentes antirrugas que possuem uma novo núcleo parental que é adequado como componentes para preparações externas para a pele, tais como cosméticos. os agentes antirrugas compreendem compostos representados pela fórmula geral (1), estereoisômeros dos mesmos ou sais farmacologicamente permissíveis dos mesmos. os ditos agentes antirrugas têm excelente eficácia para melhorar rugas e flacidez que ocorrem como um resultado de foto envelhecimento devido à exposição aos raios ultravioleta que é envelhecimento da pele com o aumento da idade. [na fórmula, r; representa um átomo de hidrogênio ou um grupo alquila reto ou ramificado com 1 a 8 carbonos. r, representa -sh, -sosh, -s-s-x,, -s-xy, - so-x3, -s0,-x4, -so,-ny4-xs ou —so,-ny5-y3. xi/-x5 independentemente são átomos de hidrogênio ou grupos hidrocarbonetos alifáticos com 1 a 8 carbonos ou um grupamento aromático com 5 a 12 carbonos em que os átomos de carbono podem estar substituídos com heteroátomos. y, - y5 independentemente representam átomos de hidrogênio ou grupos alquila retos ou ramificados com 1 a 8 carbonos. r; representa um átomo de hidrogênio ou grupo acila que possua uma cadeia alquila reta ou ramificada com 1 a 8 carbonos. r, representa um grupo aromático de 5 a 12 carbonos ou um grupo aromático policíclico condensado que pode ter grupos não substituídos ou substituídos. m representa um número inteiro de o - 3 e n representa um número inteiro de 1 ou 2.]
BRPI0921303A 2008-11-19 2009-11-12 Agente redutor de rugas, composto, e, preparação externa para a pele. BRPI0921303B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2008294995 2008-11-19
JP2008-294995 2008-11-19
PCT/JP2009/069261 WO2010058730A1 (ja) 2008-11-19 2009-11-12 シワ改善剤

Publications (3)

Publication Number Publication Date
BRPI0921303A2 BRPI0921303A2 (pt) 2015-12-29
BRPI0921303B1 BRPI0921303B1 (pt) 2022-04-12
BRPI0921303B8 true BRPI0921303B8 (pt) 2022-05-10

Family

ID=42198170

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0921303A BRPI0921303B8 (pt) 2008-11-19 2009-11-12 Agente redutor de rugas, composto, e, preparação externa para a pele.

Country Status (17)

Country Link
US (1) US8835498B2 (pt)
EP (2) EP3173063B1 (pt)
JP (3) JP5746864B2 (pt)
KR (1) KR101657323B1 (pt)
CN (1) CN102215812B (pt)
AU (1) AU2009318483B2 (pt)
BR (1) BRPI0921303B8 (pt)
CA (1) CA2742909C (pt)
ES (2) ES2781401T3 (pt)
HK (1) HK1160405A1 (pt)
IL (1) IL212909A (pt)
MX (1) MX2011004006A (pt)
MY (1) MY159355A (pt)
RU (1) RU2503443C2 (pt)
TW (1) TWI474837B (pt)
UA (1) UA107919C2 (pt)
WO (1) WO2010058730A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2524686B1 (en) * 2010-01-12 2017-06-21 Pola Chemical Industries Inc. Pigmentation-preventing or -ameliorating agent
JP5666158B2 (ja) * 2010-03-31 2015-02-12 ポーラ化成工業株式会社 肌荒れ予防又は改善剤
JP5669437B2 (ja) * 2010-05-18 2015-02-12 ポーラ化成工業株式会社 組成物
JP5669436B2 (ja) * 2010-05-18 2015-02-12 ポーラ化成工業株式会社 組成物
JP5911209B2 (ja) * 2011-06-14 2016-04-27 ポーラ化成工業株式会社 皮膚外用剤
JP2013018713A (ja) * 2011-07-07 2013-01-31 Pola Chemical Industries Inc 皮膚外用剤
JP6086706B2 (ja) * 2012-11-14 2017-03-01 ポーラ化成工業株式会社 高い紫外線吸収効果を有する皮膚外用組成物
CA3185776A1 (en) * 2014-04-03 2015-10-08 Pola Chemical Industries, Inc. Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor
FR3029410B1 (fr) * 2014-12-04 2016-12-30 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic Utilisation d'esters de 1,3-butanediol et de derives n-acyles d'acides amines comme agent de brunissage et/ou de bronzage de la peau humaine
FR3029412B1 (fr) * 2014-12-04 2018-01-26 Societe D'exploitation De Produits Pour Les Industries Chimiques Seppic Utilisation de derives n-acyles d'acide amines esterifies avec le 1,3-butanediol, comme agent antivieillissement de la peau humaine
MY194060A (en) * 2016-06-24 2022-11-10 Pola Chem Ind Inc External preparation for skin for wrinkle improvement
KR102042967B1 (ko) * 2017-03-07 2019-11-11 코스맥스 주식회사 푸코실락토오스를 포함하는 피부 노화 개선용 화장료 조성물
JP2023514458A (ja) * 2019-06-24 2023-04-05 カステラーナ，ロッサーナ トリクロロ酢酸塩及びヒドロキシ酸を含有する歯科及び皮膚科の使用のための製剤

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1035855B (de) * 1957-06-29 1958-08-07 Hans Schwarzkopf Chem Fab Haut- und Haarpflegemittel
JPS53149926A (en) * 1977-05-18 1978-12-27 Kowa Co Methylmethionine sulfonium derivative
JPS6119511A (ja) 1984-07-06 1986-01-28 Mitsubishi Electric Corp 放電加工方法とその装置
LU85558A1 (fr) * 1984-09-28 1986-04-03 Oreal Nouveaux derives naphtaleniques a action retinoique,leurs procedes de preparation et compositions medicamenteuse et cosmetique les contenant
US4757066A (en) * 1984-10-15 1988-07-12 Sankyo Company Limited Composition containing a penem or carbapenem antibiotic and the use of the same
JPS61289016A (ja) 1985-06-17 1986-12-19 Pola Chem Ind Inc 皮膚外用剤
JPH0657652B2 (ja) 1985-07-19 1994-08-03 鐘紡株式会社 皮膚老化防止化粧料
IL80270A0 (en) * 1985-10-11 1987-01-30 Cird Naphthalene derivatives,their preparation and pharmaceutical compositions containing them
JPH075461B2 (ja) * 1986-04-10 1995-01-25 三共株式会社 副作用の軽減されたペネム型またはカルバペネム型抗生物質製剤
DE3727897A1 (de) * 1987-08-21 1989-03-02 Degussa Verfahren zur herstellung von n-acylierten mercapto-(alpha)-aminosaeuren
JP2985181B2 (ja) 1989-05-31 1999-11-29 日本電気株式会社 多重変換装置
JP2999301B2 (ja) * 1991-07-25 2000-01-17 協和醗酵工業株式会社 化粧料
TW222591B (pt) * 1991-08-30 1994-04-21 Procter & Gamble
US5296500A (en) 1991-08-30 1994-03-22 The Procter & Gamble Company Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy
CA2128205C (en) 1992-01-27 2004-03-30 Hiroharu Matsuoka Methotrexate derivatives
FR2738484B1 (fr) 1995-09-07 1997-10-03 Oreal Utilisation de l'acide cysteique ou homocysteique pour favoriser la desquamation de la peau ou stimuler le renouvellement epidermique
DK0873123T3 (da) * 1995-11-06 2003-08-04 Univ Pittsburgh Inhibitorer af protein-isoprenyltransferaser
JP3569448B2 (ja) 1997-07-14 2004-09-22 鹿島石油株式会社 Ｎ−アシルアミノ酸及びこれを用いた化粧料
JPH1149629A (ja) 1997-07-31 1999-02-23 Shiseido Co Ltd 美白用化粧料
JPH1149628A (ja) 1997-07-31 1999-02-23 Shiseido Co Ltd しわ改善用化粧料
IL138297A0 (en) 1998-03-27 2001-10-31 Genentech Inc Antagonists for treatment of cd11/cd18 adhesion receptor mediated disorders
GB9828442D0 (en) 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
US20030229141A1 (en) 1999-01-08 2003-12-11 Yu Ruey J. N-acetyl cysteine and its topical use
JP2001192317A (ja) 2000-01-06 2001-07-17 Shiseido Co Ltd マトリックスメタロプロテアーゼ阻害剤
US6534038B2 (en) 2000-04-07 2003-03-18 Bristol-Myers Squibb Pharma Company Ternary ligand complexes useful as radiopharmaceuticals
US20020010128A1 (en) 2000-04-13 2002-01-24 Parks Thomas P. Treatment of hyperproliferative, inflammatory and related mucocutaneous disorders using inhibitors of mevalonate synthesis and metabolism
US7118736B2 (en) * 2001-02-22 2006-10-10 L'oreal Hair relaxer compositions comprising at least one hydroxide compound and at least one activating agent, and methods of using the same
ITMI20011022A1 (it) 2001-05-17 2002-11-17 Indena Spa Composizioni farmaceutiche e cosmetiche contro l'invecchiamento cutaneo
JP2003137807A (ja) * 2001-11-01 2003-05-14 Miyagi Kagaku Kogyo Kk コラーゲン産生促進剤、それを含む化粧品、食品および医薬品ならびに皮膚疾患の予防または改善用外用剤
JP2003267856A (ja) 2002-03-18 2003-09-25 Showa Denko Kk しわ防止用化粧料
AU2003268550A1 (en) * 2002-09-06 2004-03-29 Elan Pharmaceuticals, Inc. 1, 3-diamino-2-hydroxypropane prodrug derivatives
WO2004024939A2 (en) 2002-09-13 2004-03-25 Georgetown University Ligands for the peroxisome proliferator-activated receptor, and methods of use thereof
JP2005089304A (ja) 2003-09-12 2005-04-07 Nippon Menaade Keshohin Kk 炎症性サイトカインの産生抑制剤
JP4341501B2 (ja) * 2004-08-10 2009-10-07 東亞合成株式会社 チロシナーゼ活性阻害剤
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
CN101128117A (zh) * 2005-01-03 2008-02-20 吕伊·J·于 包含氨基糖类和氨基酸的o-乙酰水杨基衍生物的组合物
JP2007191396A (ja) 2005-01-07 2007-08-02 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP4838537B2 (ja) 2005-05-25 2011-12-14 株式会社 資生堂 不全角化抑制剤、毛穴縮小剤又は肌荒れ防止・改善剤及び皮膚外用組成物
EP1963262A2 (en) * 2005-12-15 2008-09-03 Vicuron Pharmaceuticals, Inc. N-hydroxyamide derivatives possessing antibacterial activity
JP2008105976A (ja) * 2006-10-24 2008-05-08 Shinichiro Isobe 化粧用組成物

Also Published As

Publication number Publication date
JP2017008101A (ja) 2017-01-12
KR20110086743A (ko) 2011-07-29
TW201023902A (en) 2010-07-01
AU2009318483B2 (en) 2015-03-19
BRPI0921303A2 (pt) 2015-12-29
ES2650252T3 (es) 2018-01-17
IL212909A (en) 2015-02-26
RU2011124914A (ru) 2012-12-27
MX2011004006A (es) 2011-05-19
HK1160405A1 (en) 2012-08-17
CA2742909C (en) 2017-12-19
MY159355A (en) 2016-12-30
US20110245343A1 (en) 2011-10-06
TWI474837B (zh) 2015-03-01
BRPI0921303B1 (pt) 2022-04-12
CA2742909A1 (en) 2010-05-27
EP2356979A4 (en) 2012-09-05
UA107919C2 (en) 2015-03-10
EP3173063A1 (en) 2017-05-31
CN102215812B (zh) 2014-09-10
IL212909A0 (en) 2011-07-31
AU2009318483A1 (en) 2010-05-27
CN102215812A (zh) 2011-10-12
JP5746864B2 (ja) 2015-07-08
EP3173063B1 (en) 2019-12-25
WO2010058730A1 (ja) 2010-05-27
JP6225228B2 (ja) 2017-11-01
RU2503443C2 (ru) 2014-01-10
JP2015147768A (ja) 2015-08-20
KR101657323B1 (ko) 2016-09-13
JPWO2010058730A1 (ja) 2012-04-19
ES2781401T3 (es) 2020-09-01
EP2356979A1 (en) 2011-08-17
EP2356979B1 (en) 2017-10-25
JP6239543B2 (ja) 2017-11-29
US8835498B2 (en) 2014-09-16

Similar Documents

Publication Publication Date Title
BRPI0921303B8 (pt) Agente redutor de rugas, composto, e, preparação externa para a pele.
BR112015023129A2 (pt) compostos aromáticos substituídos para o tratamento de fibrose pulmonar, fibrose hepática, fibrose da pele e fibrose cardíaca
BR112013002631A2 (pt) preparações cosméticas
BR112012033402A2 (pt) moduladores de canais de íons conforme os compostos heterocíclicos fundidos
BR112015025961A2 (pt) composto, composição cosmética ou farmacêutica, e, uso de um composto
BR112013028832A2 (pt) composição alimentícia, uso de éter de celulose e método para melhorar uma ou mais das propriedades de uma composição alimentícia
BR112016018069A2 (pt) Composições de surfactante aquoso
BR0111532A (pt) Composições de éteres de monoalquila de glicerol de armazenamento estável
BR112017003931A2 (pt) composições de surfactante aquoso
BR112013009836A2 (pt) composição cosmética de cabelo e cosmético de tratamento de cabelo
BRPI0911404A2 (pt) Derivados de pirano, sua preparação e uso dos mesmos em perfumaria
CL2011002268A1 (es) Uso de compuestos derivados de acidos grasos poliinsaturados para el tratamiento de enfermedades neurodegenerativas y neurologicas; y composicion farmaceutica o nutraceutica.
BR112014002670A2 (pt) uso de monoésteres de isossorbida como compostos antimicrobianamente ativos
BRPI0802293A2 (pt) composição cosmética e método de conferir brilho duradouro aos lábios
BR112014031168A2 (pt) composições cosméticas compreendendo agentes promotores da biossíntese de hialuronana
CO6640281A2 (es) Composiciones de cuidado oral
BR112012021556A2 (pt) processo para a preparação de peptídeos prolila substituídos e peptidomiméticos similares
BR112014002594A2 (pt) uso de diésteres de isossorbida como espessantes
BR112012017157A2 (pt) agente profilático ou de melhora da pigmentação.
AR067770A1 (es) Derivados de tiazol y ditiazol para el tratamiento de diabetes
BR112012033690A2 (pt) sais de cálcio de compostos como agentes anti-inflamatórios, imunomodulares e antitroliferativos
BR112012014196A2 (pt) agente para prevenir ou melhorar a pigmentação
CO6501175A2 (es) Derivados de benzotiazinas, su preparación y aplicación como fármacos
BR112015025476A2 (pt) composição e processo para o tratamento cosmético
BR112012006979A2 (pt) composição antioxidante

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B12B Appeal against refusal [chapter 12.2 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/11/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2675 DE 12/04/2022 QUANTO AO ENDERECO.